Medical technology breakthroughs have led to a radical transformation in patient care by enabling a greater focus on clinical outcomes. Minimally invasive or non-invasive medical technologies, for instance, not only shorten recovery time but also lower medical costs. The growth of the markets for telemedicine and drug eluting stents also demonstrate the growing trend in medicine of using cutting-edge technology to enhance clinical outcomes. MarketsandMarkets tracks vital medical devices markets such as orthopedic devices, cardiovascular devices, surgical devices, therapeutic devices, mobility assist devices, self diagnostic devices, and neurostimulators.
Medical devices refer to a broad range of instruments, machines, implants, apparatuses, software, or other similar items that are specifically designed and manufactured for medical purposes. These devices are used in the prevention, diagnosis, treatment, or management of diseases, injuries, or disabilities in humans.
Medical devices can vary in complexity and function. They can be as simple as tongue depressors, thermometers, or bandages, or as advanced as robotic surgical systems, pacemakers, or imaging machines such as MRI (Magnetic Resonance Imaging) scanners.
The primary objective of medical devices is to improve the quality of patient care by providing accurate and reliable diagnostic information, delivering therapies, or assisting in medical procedures. They are often regulated by governmental bodies, such as the Food and Drug Administration (FDA) in the United States, to ensure their safety, effectiveness, and quality.
Medical devices play a crucial role in modern healthcare and are utilized in various settings, including hospitals, clinics, ambulatory care centers, and home healthcare. They are developed through rigorous research, design, testing, and manufacturing processes to meet specific medical requirements and comply with relevant regulations and standards.
Futuristic scope –
The field of medical devices is constantly evolving, and there are several futuristic trends and advancements that hold great potential for improving healthcare in the coming years. Here are some areas with exciting prospects:
It's important to note that while these futuristic possibilities hold tremendous promise, their successful implementation will require extensive research, rigorous testing, regulatory approvals, and careful consideration of ethical, privacy, and security aspects.
Merger & Acquisition –
Merger and acquisition (M&A) activities in the medical device industry involve the consolidation, integration, or purchase of medical device companies by other companies. These transactions are typically aimed at achieving strategic objectives, such as expanding product portfolios, entering new markets, gaining competitive advantages, or leveraging synergies.
M&A activities in the medical device sector can take various forms, including:
M&A transactions in the medical device industry are subject to regulatory scrutiny to ensure compliance with antitrust laws and to assess potential impacts on competition and patient welfare. Companies must also carefully consider factors such as financial valuation, integration challenges, cultural alignment, intellectual property rights, and regulatory compliance during the M&A process.
Overall, M&A activities in the medical device sector are driven by strategic objectives and aim to create synergies, drive growth, and enhance competitiveness in an evolving healthcare landscape.
Key segments in Medical Devices:
The medical device industry encompasses various segments that cater to different healthcare needs and specialties. Here are some key segments within the medical device industry:
These segments represent a broad overview of the medical device industry, and there are numerous subcategories and specialized devices within each segment. Advances in technology and innovation continue to drive the development of new and improved medical devices across these segments, aiming to enhance patient care and improve healthcare outcomes.
subsegments in Medical Devices:
The medical device industry consists of numerous subsegments that focus on specific areas of healthcare and address specialized needs. Here are some subsegments within the key segments of medical devices:
Diagnostic Devices:
Therapeutic Devices:
Surgical Devices:
Monitoring Devices:
Rehabilitation and Assistive Devices:
Implantable Devices:
Home Healthcare Devices:
These subsegments represent specific areas of focus within each key segment of medical devices, catering to specialized medical needs and conditions. They reflect the diverse range of medical devices available to address various healthcare challenges and improve patient outcomes.
Medical Devices Ecosystem:
The medical devices ecosystem encompasses a wide range of stakeholders, each playing a distinct role in the development, deployment, and utilization of medical devices to improve healthcare outcomes and patient well-being.
Top players:
The medical device industry is home to several top players that have established themselves as leaders in the global market. Here are some of the prominent companies in the medical device sector:
These companies have established strong market positions through their product portfolios, technological innovation, global presence, and commitment to advancing healthcare. However, it's important to note that the medical device industry is highly competitive, and there are several other notable players contributing to the advancement of medical technology.
High grown opportunities:
The medical device industry offers numerous high-growth opportunities driven by various factors such as technological advancements, increasing healthcare needs, and evolving market dynamics. Here are some key areas that present significant growth opportunities in the medical device sector:
It's important to note that the medical device industry is subject to regulatory requirements and challenges related to reimbursement, intellectual property, and market competition. Companies that can navigate these complexities while addressing evolving healthcare needs stand to benefit from the high-growth opportunities within the medical device sector.
Challenges in Medical Devices Industry:
The medical device industry faces several challenges that impact its growth, innovation, and market dynamics. Here are some key challenges in the medical device industry:
Navigating these challenges requires strategic planning, collaboration with stakeholders, investment in research and development, and a deep understanding of market dynamics. Companies that can effectively address these challenges have a better chance of succeeding in the competitive medical device industry.
High CAGR geography:
The Compound Annual Growth Rate (CAGR) of the medical device industry can vary across different geographies due to factors such as population demographics, healthcare infrastructure, regulatory environments, and economic growth. While it is difficult to predict the precise CAGR for specific geographies, there are regions that have shown potential for high growth in the medical device sector. Here are a few geographies that have been identified as having a high CAGR for medical devices:
Medical technology breakthroughs have led to a radical transformation in patient care by enabling a greater focus on clinical outcomes. Minimally invasive or non-invasive medical technologies, for instance, not only shorten recovery time but also low ....see more
The global orthopedic braces and supports market, valued at US$3.8 billion in 2024, stood at US$4.0 billion in 2025 and is projected to advance at a resilient CAGR of 6.5% from 2025 to 2030, culminating in a forecasted valuation of US$5.5 billion by the end of the period. A key driver of the orthopedic braces and supports market is the increasing prevalence of musculoskeletal disorders and sports-related injuries, especially among aging populations and active groups.
The global nuclear medicine equipment market, valued at US$6.33 billion in 2024, stood at US$6.63 billion in 2025 and is projected to advance at a resilient CAGR of 4.62% from 2025 to 2030, culminating in a forecasted valuation of US$8.31 billion by the end of the period.
The global veterinary infectious disease diagnostics market, valued at US$2.66 billion in 2024, stood at US$2.87 billion in 2025 and is projected to advance at a resilient CAGR of 8.0% from 2025 to 2030, culminating in a forecasted valuation of US$4.22 billion by the end of the period.
The global endoscopic submucosal dissection market, valued at US$0.46 billion in 2024, stood at US$0.50 billion in 2025 and is projected to advance at a resilient CAGR of 8.4% from 2025 to 2030, culminating in a forecasted valuation of US$0.75 billion by the end of the period. The increasing adoption of endoscopic submucosal dissection (ESD) in Western countries is becoming a significant growth driver for the global ESD market.
The global surgical microscopes market, valued at US$1.33 billion in 2024, stood at US$1.51 billion in 2025 and is projected to advance at a resilient CAGR of 11.4% from 2025 to 2030, culminating in a forecasted valuation of US$2.69 billion by the end of the period. The surgical microscopes market is set to grow, driven by emerging countries like India, Brazil, and Vietnam. These nations are experiencing rapid economic development, which is leading to a rising middle class with increasing disposable incomes.
The global laparoscopic instruments market, valued at US$10.23 billion in 2024, stood at US$11.07 billion in 2025 and is projected to advance at a resilient CAGR of 8.7% from 2025 to 2030, culminating in a forecasted valuation of US$16.78 billion by the end of the period. Rising prevalence of lifestyle-related diseases such as obesity, gallbladder issues, and gastrointestinal disorders, along with a growing demand for minimally invasive surgeries across countries such as China, India, Japan, and Southeast Asian nations, drive market growth.
The global medical device contract manufacturing market, valued at US$78.58 billion in 2024, stood at US$83.77 billion in 2025 and is projected to advance at a resilient CAGR of 10.9% from 2025 to 2030, culminating in a forecasted valuation of US$140.84 billion by the end of the period.
The global ASEAN infusion pump market, valued at US$1.18 billion in 2024, stood at US$1.26 billion in 2025 and is projected to advance at a resilient CAGR of 7.1% from 2025 to 2030, culminating in a forecasted valuation of US$1.78 billion by the end of the period. The ASEAN infusion pump market is experiencing significant growth, driven by heightened healthcare awareness and enhanced access to sophisticated medical technologies throughout the region.
The global veterinary diagnostics market, valued at US$3.42 billion in 2024, stood at US$3.68 billion in 2025 and is projected to advance at a resilient CAGR of 7.8% from 2025 to 2030, culminating in a forecasted valuation of US$5.36 billion by the end of the period.
The global medical equipment maintenance market, valued at US$55.22 billion in 2024, stood at US$66.68 billion in 2025 and is projected to advance at a resilient CAGR of 10.8% from 2025 to 2030, culminating in a forecasted valuation of US$101.52 billion by the end of the period. The medical equipment maintenance market expansion is driven by the increasing demand for appropriate and accurately functioning medical devices, higher healthcare investments, and increased attention to patient safety and equipment uptime.
The global Brazil advanced wound dressings market, valued at US$117.79 million in 2024, stood at US$129.84 million in 2025 and is projected to advance at a resilient CAGR of 10.4% from 2025 to 2030, culminating in a forecasted valuation of US$213.03 million by the end of the period. The rising prevalence of diabetes and obesity, coupled with an increasing incidence of traumatic and burn injuries, significantly contributes to market expansion.
The global neonatal care equipment market, valued at US$2.0 billion in 2024, stood at US$2.2 billion in 2025 and is projected to advance at a resilient CAGR of 5.6% from 2025 to 2030, culminating in a forecasted valuation of US$2.8 billion by the end of the period. The neonatal care equipment market is driven by rising preterm birth rates, advancements in neonatal technology, and increasing government initiatives to reduce infant mortality.
The global liquid biopsy market, valued at US$3.65 billion in 2024, stood at US$4.03 billion in 2025 and is projected to advance at a resilient CAGR of 11.8% from 2025 to 2030, culminating in a forecasted valuation of US$7.05 billion by the end of the period. The increasing global cancer incidence and the growing emphasis on early and precise disease detection primarily drive this market expansion.
The global incontinence care products market, valued at US$13.99 billion in 2024, stood at US$14.81 billion in 2025 and is projected to advance at a resilient CAGR of 7.1% from 2025 to 2030, culminating in a forecasted valuation of US$20.85 billion by the end of the period. A change in healthcare delivery models drives the ICP market as home-based and long-term care is prioritized.
The global lateral flow assays market, valued at US$7.93 billion in 2024, stood at US$8.51 billion in 2025 and is projected to advance at a resilient CAGR of 8.0% from 2025 to 2030, culminating in a forecasted valuation of US$12.52 billion by the end of the period. Prominent players in the lateral flow assays market include Abbott Laboratories (US), F. Hoffman-La Roche Ltd. (Switzerland), Danaher Corporation (US), Becton, Dickinson and Company (US), QuidelOrtho Corporation (US), Siemens AG (Germany), bioMérieux SA (France), Thermo Fisher Scientific, Inc. (US), Revvity, Inc. (US), Hologic Inc. (US), QIAGEN N.V. (Netherlands), Merck KGaA (Germany), Surmodics, Inc. (US), and OraSure Technologies Inc. (US).
The global electrophysiology market, valued at US$11.41 billion in 2024, stood at US$12.55 billion in 2025 and is projected to advance at a resilient CAGR of 11.6% from 2025 to 2030, culminating in a forecasted valuation of US$21.72 billion by the end of the period. The rise of the electrophysiology market can be attributed to several drivers: the increasing prevalence of cardiovascular diseases, including arrhythmias and atrial fibrillation; patients and healthcare providers are increasingly favoring minimally invasive procedures over traditional surgical interventions; electrophysiological techniques, such as catheter ablation, offer less invasive options for treating certain cardiac arrhythmias; and government support and initiatives aimed at improving healthcare infrastructure and funding research and development in electrophysiology also contribute to market growth.
The global surgical instrument tracking systems market, valued at US$314.2 million in 2024, stood at US$371.4 million in 2025 and is projected to advance at a resilient CAGR of 15.2% from 2025 to 2030, culminating in a forecasted valuation of US$751.2 million by the end of the period. The surgical instrument tracking systems market is primarily driven by the increasing need for patient safety, regulatory compliance, and inventory management in healthcare facilities.
The global dental imaging market, valued at US$3.08 billion in 2024, stood at US$3.26 billion in 2025 and is projected to advance at a resilient CAGR of 7.5% from 2025 to 2030, culminating in a forecasted valuation of US$4.69 billion by the end of the period. The prominent players in the dental imaging market include Envista Holdings Corporation (US), Planmeca Oy (Finland), ACTEON (UK), DENTSPLY SIRONA Inc. (US), Carestream Dental LLC (US), VATECH (South Korea), Owandy Radiology, Inc. (France), DÜRR DENTAL AG (Germany), Midmark Corporation (US), Genoray Co., Ltd. (South Korea), Asahi Roentgen Co., Ltd. (Japan), 3Shape (Denmark), PreXion, Inc. (US), Ningbo Runyes Medical Instrument Co. Ltd.(China), Cefla Medical Equipment (Italy), Apteryx Imaging (Canada), Yoshida Dental Mfg. Co., Ltd. (Japan), Align Technology Inc. (US), J. MORITA CORP (Japan), and FONA Srl (Italy).
The global surgical sutures market, valued at US$4.56 billion in 2024, stood at US$4.84 billion in 2025 and is projected to advance at a resilient CAGR of 6.5% from 2025 to 2030, culminating in a forecasted valuation of US$6.65 billion by the end of the period. The demand for surgical sutures is on the rise, driven largely by the increasing frequency of surgical interventions worldwide.
The global wound care market, valued at US$20.97 billion in 2024, stood at US$22.22 billion in 2025 and is projected to advance at a resilient CAGR of 6.5% from 2025 to 2030, culminating in a forecasted valuation of US$30.48 billion by the end of the period. The wound care market is primarily driven by the increasing cases of traumatic and burn injuries, growing prevalence of chronic diseases, and rising geriatric population. These factors have contributed to the higher demand for effective wound management solutions.
The global defibrillator market, valued at US$11.29 billion in 2024, stood at US$11.99 billion in 2025 and is projected to advance at a resilient CAGR of 6.5% from 2025 to 2030, culminating in a forecasted valuation of US$16.44 billion by the end of the period. Major players in the defibrillator market include Medtronic (Ireland), Stryker (US), Koninklijke Philips N.V. (Netherlands), Asahi Kasei Corporation (Japan), Boston Scientific Corporation (US), Abbott (US), MicroPort Scientific Corporation (China), Nihon Kohden Corporation (Japan), Biotronik (Germany), and CU Medical Systems, Inc. (South Korea).
The global hearing aids market, valued at US$9.74 billion in 2024, stood at US$10.35 billion in 2025 and is projected to advance at a resilient CAGR of 6.8% from 2025 to 2030, culminating in a forecasted valuation of US$14.42 billion by the end of the period. Market growth in the Asia Pacific can be attributed to the rising elderly population and growing demand for ENT services. Increasing healthcare investments and growing medical tourism also contribute to regional market expansion.
The global X-ray detectors market, valued at US$3.2 billion in 2024, stood at US$3.4 billion in 2025 and is projected to advance at a resilient CAGR of 5.5% from 2025 to 2030, culminating in a forecasted valuation of US$4.4 billion by the end of the period. The key players operating in the x-ray detectors market are Analogic Corporation (US), Agfa-Gevaert Group (Belgium), Varex Imaging (US), Thales Group (France), Canon Inc. (Japan), Konica Minolta, Inc. (Japan), Carestream Health (US), FUJIFILM Holdings Corporation (Japan), and Hamamatsu Photonics K.K. (Japan), among others.
The global autoimmune disease diagnosis market, valued at US$5.26 billion in 2024, stood at US$5.57 billion in 2025 and is projected to advance at a resilient CAGR of 8.3% from 2025 to 2031, culminating in a forecasted valuation of US$8.98 billion by the end of the period. The autoimmune disease diagnosis market is consistently growing, fueled by several key factors. These include the rising prevalence of autoimmune disease, growing awareness about early and accurate diagnosis, increasing research activities, and rapid advancements in diagnostic technologies.
The global biosurgery market, valued at US$14.96 billion in 2024, stood at US$15.83 billion in 2025 and is projected to advance at a resilient CAGR of 6.4% from 2025 to 2030, culminating in a forecasted valuation of US$21.59 billion by the end of the period. Some of the prominent players operating in the market include market Medtronic (Ireland), Johnson & Johnson Services, Inc. (US), Baxter (US), Becton, Dickinson and Company (BD) (US), B. Braun SE (Germany), Stryker (US), Integra Lifesciences Holdings Corporation (US), CSL Ltd. (Australia), Hemostasis LLC (US), and Pfizer Inc. (US), among others.
The global knee replacement surgery market, valued at US$10.86 billion in 2023, stood at US$12.00 billion in 2025 and is projected to advance at a resilient CAGR of 6.1% from 2025 to 2030, culminating in a forecasted valuation of US$16.17 billion by the end of the period. The key factor propelling the market is the increasing prevalence of osteoarthritis, particularly among the aging population. This increase in cases is driving a higher demand for surgical interventions, including total and partial knee replacements.
The global ECG sensor patches market, valued at US$0.95 billion in 2024, stood at US$1.05 billion in 2025 and is projected to advance at a resilient CAGR of 12.0% from 2025 to 2032, culminating in a forecasted valuation of US$2.32 billion by the end of the period. The growth is mainly attributed to the rising target patient population and increasing cases of CVD.
The global hemostats market, valued at US$2.8 billion in 2024, stood at US$2.9 billion in 2025 and is projected to advance at a resilient CAGR of 6.4% from 2025 to 2030, culminating in a forecasted valuation of US$4.0 billion by the end of the period. The escalation in global accident rates has led to a surge in surgical procedures characterized by extended operating durations.
The global sleep apnea devices market, valued at US$6.4 billion in 2024, stood at US$6.9 billion in 2025 and is projected to advance at a resilient CAGR of 7.6% from 2025 to 2032, culminating in a forecasted valuation of US$ 11.6 billion by the end of the period. The sleep apnea devices market is experiencing significant growth, primarily driven by the increasing integration of telemedicine, mobile health (mHealth), and artificial intelligence in the diagnostic and therapeutic processes for sleep apnea.
The global oral care market, valued at US$34.97 billion in 2024, stood at US$37.21 billion in 2025 and is projected to advance at a resilient CAGR of 6.4% from 2025 to 2030, culminating in a forecasted valuation of US$53.29 billion by the end of the period. The expansion of the oral care market can be attributed to several key factors, including a growing prevalence of untreated oral hygiene issues that lead to dental caries and periodontal diseases.
The global organ preservation market, valued at US$0.1 billion in 2024, stood at US$0.2 billion in 2025 and is projected to advance at a resilient CAGR of 6.8% from 2025 to 2030, culminating in a forecasted valuation of US$0.3 billion by the end of the period. The organ preservation market is experiencing robust growth fueled by rising incidence of chronic diseases, organ failure, and advancements in transplantation procedures.
The global respiratory care devices market, valued at US$22.2 billion in 2024, stood at US$23.6 billion in 2025 and is projected to advance at a resilient CAGR of 7.3% from 2025 to 2030, culminating in a forecasted valuation of US$33.6 billion by the end of the period. Various demographic, medical, and environmental factors propel market growth in respiratory care equipment. Among these is the increase in the global prevalence of respiratory conditions.
The global blood pressure cuffs market, valued at US$0.6 billion in 2024, stood at US$0.7 billion in 2025 and is projected to advance at a resilient CAGR of 9.0% from 2025 to 2032, culminating in a forecasted valuation of US$1.3 billion by the end of the period. This growth is primarily fueled by the expanding elderly population, which is at a higher risk of developing hypertension and associated cardiovascular complications.
The global advanced wound care market, valued at US$12.48 billion in 2024, stood at US$13.37 billion in 2025 and is projected to advance at a resilient CAGR of 7.6% from 2025 to 2030, culminating in a forecasted valuation of US$19.32 billion by the end of the period. The advanced wound care market is primarily driven by several factors: the increasing geriatric population, the rising prevalence of chronic diseases, and a growing number of traumatic and burn injuries.
The global pulse oximeter market, valued at US$3.59 billion in 2024, stood at US$3.92 billion in 2025 and is projected to advance at a resilient CAGR of 8.7% from 2025 to 2032, culminating in a forecasted valuation of US$7.03 billion by the end of the period. The growth of this market is primarily driven by the rising prevalence of respiratory diseases, increasing prevalence of congenital heart disease (CHD) in children, a growing number of surgical procedures and hospitalizations, an increasing geriatric population, and subsequent rise in chronic diseases, technological advancements in pulse oximeter devices, growing investments in healthcare infrastructure, and the outbreak of infectious respiratory diseases.
The global digital stethoscopes market, valued at US$467.7 million in 2024, stood at US$491.7 million in 2025 and is projected to advance at a resilient CAGR of 5.5% from 2025 to 2032, culminating in a forecasted valuation of US$717.3 million by the end of the period. The rising prevalence of chronic diseases, such as cardiovascular and respiratory conditions, combined with the introduction and approval of advanced digital stethoscopes, is driving significant market growth.
The global single-use surgical instruments (SUSI) market, valued at US$5.60 billion in 2024, stood at US$5.92 billion in 2025 and is projected to advance at a resilient CAGR of 5.7% from 2025 to 2030, culminating in a forecasted valuation of US$7.80 billion by the end of the period. The rise of minimally invasive and short-stay surgeries has significantly increased the demand for single-use surgical instruments.
The global medical display market, valued at US$2.50 billion in 2024, stood at US$2.64 billion in 2025 and is projected to advance at a resilient CAGR of 5.5% from 2025 to 2030, culminating in a forecasted valuation of US$3.45 billion by the end of the period. The medical displays market is experiencing rapid growth due to the increasing demand for accurate and high-quality diagnostic imaging. This demand is driven by the rise in chronic diseases and an aging population.
The global soft tissue repair market, valued at US$15.12 billion in 2024, stood at US$15.96 billion in 2025 and is projected to advance at a resilient CAGR of 5.1% from 2025 to 2030, culminating in a forecasted valuation of US$20.52 billion by the end of the period. The soft tissue repair market is witnessing significant growth driven by demographic trends, technological advancements, and evolving clinical practices.
The global insulin delivery devices market, valued at US$32.6 billion in 2024, stood at US$35.3 billion in 2025 and is projected to advance at a resilient CAGR of 8.3% from 2025 to 2030, culminating in a forecasted valuation of US$ 52.7 billion by the end of the period. The insulin delivery devices market is experiencing steady growth, primarily due to the increasing number of individuals diagnosed with diabetes. The rising prevalence of type 1 diabetes, in particular, is driving the demand for insulin delivery devices, as patients with this condition rely on insulin to manage their blood glucose levels.
The global dental 3D printing market, valued at US$3.40 billion in 2024, stood at US$3.96 billion in 2025 and is projected to advance at a resilient CAGR of 20.5% from 2025 to 2030, culminating in a forecasted valuation of US$ 10.06 billion by the end of the period. The dental 3D printing market in the Asia Pacific region is anticipated to grow as countries like India and Vietnam undergo rapid economic development, resulting in a rising middle class with increasing disposable income.
The global medical connectors market, valued at US$1.64 billion in 2024, stood at US$1.74 billion in 2025 and is projected to advance at a resilient CAGR of 7.1% from 2025 to 2030, culminating in a forecasted valuation of US$ 2.45 billion by the end of the period. The growth of the Asia Pacific medical connectors market is strongly supported by the rapid expansion of healthcare infrastructure and an increased adoption of advanced medical technologies across developing nations.
The global pressure monitoring market, valued at US$13.63 billion in 2024, stood at US$14.56 billion in 2025 and is projected to advance at a resilient CAGR of 8.3% from 2025 to 2032, culminating in a forecasted valuation of US$ 25.48 billion by the end of the period. The pressure monitoring market is experiencing significant growth driven by medical, technological, and demographic factors. The rising prevalence of chronic conditions such as hypertension, cardiovascular diseases, and respiratory disorders has led to an increased demand for accurate and continuous pressure monitoring in both clinical and home settings.
The global infusion pump market, valued at US$18.5 billion in 2024, stood at US$19.9 billion in 2025 and is projected to advance at a resilient CAGR of 7.4% from 2025 to 2030, culminating in a forecasted valuation of US$ 28.3 billion by the end of the period. The infusion pump market is expanding rapidly, driven by significant technological advancements in smart, interconnected, and automated systems that optimize the precision and safety of infusion therapy.
The global patient temperature monitoring market, valued at US$2.31 billion in 2024, stood at US$2.44 billion in 2025 and is projected to advance at a resilient CAGR of 6.7% from 2025 to 2032, culminating in a forecasted valuation of US$3.85 billion by the end of the period. The patient temperature monitoring market is experiencing substantial growth due to several pivotal factors. Key drivers include a burgeoning global population and an escalating incidence of infectious diseases.
The global Diagnostic Electrocardiograph/ECG market, valued at US$8.59 billion in 2024, stood at US$9.19 billion in 2025 and is projected to advance at a resilient CAGR of 7.4% from 2025 to 2032, culminating in a forecasted valuation of US$15.18 billion by the end of the period. The growth in the ECG diagnostic market can be attributed to several critical factors. The rising prevalence of chronic conditions, particularly CVDs, is a significant driver.
The global dental soft-tissue regeneration market, valued at US$0.36 billion in 2024, stood at US$0.38 billion in 2025 and is projected to advance at a resilient CAGR of 6.8% from 2025 to 2030, culminating in a forecasted valuation of US$ 0.53 billion by the end of the period. The growth of this market can be attributed to the expansion of pharmaceutical manufacturing facilities, increased demand for advanced biomaterials, and the rapid growth of contract manufacturing companies.
The global patient handling equipment market, valued at US$11.8 billion in 2024, stood at US$12.4 billion in 2025 and is projected to advance at a resilient CAGR of 5.8% from 2025 to 2030, culminating in a forecasted valuation of US$16.4 billion by the end of the period. The patient handling equipment market is experiencing steady growth, primarily driven by the increasing prevalence of chronic diseases such as neurological disorders & cardiovascular conditions.
Global coagulation analyzers market valued at $3516.0M in 2024, reached $3,770.9M in 2025, and is projected to grow at a robust 7.2% CAGR, hitting $5,335.9M by 2030. The market is experiencing steady growth, primarily driven by the increasing prevalence of blood clotting disorders such as hemophilia and deep vein thrombosis. As the global population ages and chronic illnesses become more common, the demand for quick and accurate diagnostic tools continues to rise.
Global HLA typing market valued at $1.6B in 2024, reached $1.7B in 2025, and is projected to grow at a robust 6.0% CAGR, hitting $2.3B by 2030. The HLA typing market is driven by the increasing use of infectious diseases and the rate of patients suffering from end-stage organ failure.